The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease

被引：100
作者：
Kikuchi, Kiyoshi [1 ,2 ,3 ]
Tancharoen, Salunya [1 ]
Takeshige, Nobuyuki [3 ]
Yoshitomi, Munetake [3 ]
Morioka, Motohiro [3 ]
Murai, Yoshinaka [2 ]
Tanaka, Eiichiro [2 ]
机构：
[1] Mahidol Univ, Dept Pharmacol, Fac Dent, Bangkok 10400, Thailand
[2] Kurume Univ, Sch Med, Div Brain Sci, Dept Physiol, Kurume, Fukuoka 8300011, Japan
[3] Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2013年 / 14卷 / 07期
关键词：
edaravone; cardiovascular disease; free radical scavenger; TRANSIENT FOCAL ISCHEMIA; ENDOTHELIAL NITRIC-OXIDE; PERMEABILITY TRANSITION PORE; OXYGEN-FREE-RADICALS; MOBILITY GROUP BOX-1; OXIDATIVE STRESS; REPERFUSION INJURY; CEREBRAL-ISCHEMIA; NAD(P)H OXIDASE; IN-VITRO;
D O I：
10.3390/ijms140713909
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Edaravone was originally developed as a potent free radical scavenger, and has been widely used to treat acute ischemic stroke in Japan since 2001. Free radicals play an important role in the pathogenesis of a variety of diseases, such as cardiovascular diseases and stroke. Therefore, free radicals may be targets for therapeutic intervention in these diseases. Edaravone shows protective effects on ischemic insults and inflammation in the heart, vessel, and brain in experimental studies. As well as scavenging free radicals, edaravone has anti-apoptotic, anti-necrotic, and anti-cytokine effects in cardiovascular diseases and stroke. Edaravone has preventive effects on myocardial injury following ischemia and reperfusion in patients with acute myocardial infarction. Edaravone may represent a new therapeutic intervention for endothelial dysfunction in the setting of atherosclerosis, heart failure, diabetes, or hypertension, because these diseases result from oxidative stress and/or cytokine-induced apoptosis. This review evaluates the potential of edaravone for treatment of cardiovascular disease, and covers clinical and experimental studies conducted between 1984 and 2013. We propose that edaravone, which scavenges free radicals, may offer a novel option for treatment of cardiovascular diseases. However, additional clinical studies are necessary to verify the efficacy of edaravone.
引用
收藏
页码：13909 / 13930
页数：22
相关论文
共 150 条
[1]   Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients [J].
Abou-Seif, MAM ;
Youssef, AA .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (07) :618-623
[2]   Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups [J].
Adams, Harold P., Jr. ;
del Zoppo, Gregory ;
Alberts, Mark J. ;
Bhatt, Deepak L. ;
Brass, Lawrence ;
Furlan, Anthony ;
Grubb, Robert L. ;
Higashida, Randall T. ;
Jauch, Edward C. ;
Kidwell, Chelsea ;
Lyden, Patrick D. ;
Morgenstern, Lewis B. ;
Qureshi, Adnan I. ;
Rosenwasser, Robert H. ;
Scott, Phillip A. ;
Wijdicks, Eelco F. M. .
STROKE, 2007, 38 (05) :1655-1711
[3]   Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats [J].
Amemiya, S ;
Kamiya, T ;
Nito, C ;
Inaba, T ;
Kato, K ;
Ueda, M ;
Shimazaki, K ;
Katayama, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 516 (02) :125-130
[4]  
[Anonymous], 2006, LANCET, V368, P1548
[5]  
[Anonymous], 1996, Stroke, V27, P1453, DOI DOI 10.1161/01.STR.27.9.1453
[6]   5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels - Effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling [J].
Antoniades, Charalambos ;
Shirodaria, Cheerag ;
Warrick, Nicholas ;
Cai, Shijie ;
de Bono, Joseph ;
Lee, Justin ;
Leeson, Paul ;
Neubauer, Stefan ;
Ratnatunga, Chandi ;
Pillai, Ravi ;
Refsum, Helga ;
Channon, Keith M. .
CIRCULATION, 2006, 114 (11) :1193-1201
[7]   Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy [J].
Arumugam, Somasundaram ;
Thandavarayan, Rajarajan A. ;
Veeraveedu, Punniyakoti T. ;
Nakamura, Takashi ;
Arozal, Wawaimuli ;
Sari, Flori R. ;
Giridharan, Vijayasree V. ;
Soetikno, Vivian ;
Palaniyandi, Suresh S. ;
Harima, Meilei ;
Suzuki, Kenji ;
Nagata, Masaki ;
Kodama, Makoto ;
Watanabe, Kenichi .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (09) :2176-2185
[8]   Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant [J].
Arumugam, Somasundaram ;
Thandavarayan, Rajarajan A. ;
Veeraveedu, Punniyakoti T. ;
Giridharan, Vijayasree V. ;
Soetikno, Vivian ;
Harima, Meilei ;
Suzuki, Kenji ;
Nagata, Masaki ;
Tagaki, Ritsuo ;
Kodama, Makoto ;
Watanabe, Kenichi .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 93 (02) :183-189
[9]   Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial [J].
Asano, T ;
Takakura, K ;
Sano, K ;
Kikuchi, H ;
Nagai, H ;
Saito, I ;
Tamura, A ;
Ochiai, C ;
Sasaki, T .
JOURNAL OF NEUROSURGERY, 1996, 84 (05) :792-803
[10]   Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein [J].
Aviram, M ;
Rosenblat, M ;
Etzioni, A ;
Levy, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (09) :1069-1079
12345678910